Table 2 105 Cochrane reviews with meaningful mortality effect size focusing on the prespecified conditions
From: Prioritising Cochrane reviews to be updated with health equity focus
19 conditions | Number of Cochrane Reviews with mortality reduction and effect size < 0.67 or > 1.5 |
|---|---|
Acute lymphoid leukaemia treatment | 1 |
Antiretroviral therapy coverage | 3 |
Asthma | 4 |
Breast Cancer | 2 |
Cervical Cancer | 3 |
Chagas disease | 1 |
Chronic kidney disease | 16 |
Chronic obstructive pulmonary disease treatment | 12 |
Colon and rectum cancer treatment | 5 |
Diabetes | 10 |
Diarrhoea treatment | 1 |
Diphtheria-tetanus-pertussis vaccine coverage | 1 |
Epilepsy | 1 |
Ischaemic heart disease | 7 |
Lower respiratory infections | 7 |
Malaria | 8 |
Schistosomiasis | 1 |
Stroke | 16 |
Tuberculosis | 6 |